Year: 2026
Type: preprint
Abstract: channels encoded by the human Ether-à-go-go-Related Gene (hERG) can cause long QT syndrome and life-threatening cardiac arrhythmias, yet the molecular mechanisms that determine this risk remain unclear. A process that may counteract arrhythmogenic hERG block, termed facilitation, is common to many clinically-approved hERG blockers including nifekalant, amiodarone, promethazine, imipramine, nortriptyline, haloperidol, verapamil, carvedilol, metoprolol, propranolol, quinidine, fluoxetine, and chlorpheniramine. Facilitation is an increase in hERG current, under certain conditions, due to these blockers. Here, we propose that an agonism-while-blocking mechanism undergirds facilitation. We focus on nifekalant, a Class III antiarrhythmic drug and exemplar hERG blocker that induces facilitation. We tested the hypothesis that nifekalant opens hERG channel gates while blocking, and that unblock of these open-yet-blocked channels results in supranormal hERG current. We develop rate-theory kinetic models to identify features of agonism-while-blocking that produce facilitation. We generate atomistic models that predict that nifekalant blocks the hERG conduction path while modulating the intracellular conduction gate. Voltage-clamp measurements reveal that agonism-while-blocking undergirds nifekalant block and facilitation. We speculate that this agonism-while-blocking mechanism contributes to the relative safety of hERG blockers that induce facilitation.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G120822750, G1373895113, Digital Twins from the Atom to the Rhythm, In silico safety pharmacology, G2352382927, G2391992532, Molecular Mechanisms of Potassium Channel Facilitation by Blockers and its Impact on Arrhythmias, Training Program in Basic and Translational Cardiovascular Science, G3554245083, Predictive multiscale in silico cardio-pharmacology, Metabolic Control of Cardiac Pacemaking, G5514250563, G5820158877, G710220600, 構造情報を基盤とした薬物のカリウムチャネル遮断・促進作用と催不整脈性の予測と制御, G7677575225, G7949675991, G8674984079, G8883367568, G9000007450, G9000098431, G9000118024
OpenAlex ID: W7163344533
Cites:
Cited by:
Related to:
